Karen Bernstein - May 17, 2021 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Karen Bernstein by PoA
Stock symbol
OVID
Transactions as of
May 17, 2021
Transactions value $
$0
Form type
4
Date filed
5/18/2021, 08:51 PM
Next filing
Jun 11, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (Right to Buy) Award $0 +1.75K $0.00 1.75K May 17, 2021 Common Stock 1.75K $3.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date.